title: Dural venous sinus thrombosis following intravitreal bevacizumab.
authors.affiliation: Department of Neurology, Comprehensive Stroke Care Program, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.
authors.forename: Sinchu C
authors.initials: SC
authors.lastname: Maniangatt
authors.affiliation: Department of Neurology, Comprehensive Stroke Care Program, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.
authors.forename: Madhukar
authors.initials: M
authors.lastname: Trivedi
authors.affiliation: Department of Neurology, Comprehensive Stroke Care Program, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.
authors.forename: Sapna E
authors.initials: SE
authors.lastname: Sreedharan
authors.affiliation: Department of Neurology, Comprehensive Stroke Care Program, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.
authors.forename: E R
authors.initials: ER
authors.lastname: Jayadevan
authors.affiliation: Department of Neurology, Comprehensive Stroke Care Program, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.
authors.forename: P N
authors.initials: PN
authors.lastname: Sylaja
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D000068258:Bevacizumab / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D058449:Intravitreal Injections; D008268:Macular Degeneration / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012851:Sinus Thrombosis, Intracranial / Q000139:chemically induced* / Q000000981:diagnostic imaging*
chemical_list: D000911:Antibodies, Monoclonal; D000068258:Bevacizumab